Asian Spectator

Times Advertising

Menarini Group's Elacestrant Marketing Authorization Applicati...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
FLORENCE, Italy and NEW YORK, Aug. 19, 2022 / PRNewswire-AsiaNet/ -- - Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line (2L) and third-line (3L) ER+/HER2- advanced or metastatic breast cancer in the European Union...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Legal Risks Every Business Owner Should Know

Running a business in Australia comes with a degree of legal exposure that many owners underestimate until a problem is already at their door. From contractual disputes to employment matters, the le...

Jerat algoritma: AI perburuk beban ganda ojol dan kurir perempuan di Indonesia

● Sistem AI mengeksploitasi tenaga kerja informal melalui ekstraksi data dan pengalihan risiko kepada mereka.● Algoritma merugikan perempuan karena mengabaikan realitas beban domestik, isu...

Narasi “kebangkitan batu bara” bermunculan efek perang Iran, tapi data menunjukkan fakta sebaliknya

● Di tengah krisis energi global, data menunjukkan penggunaan batu bara dan gas justru turun, sementara energi terbarukan meningkat.● Tren penurunan ekspor baru bara di Indonesia sudah ter...